×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HELP – cybin inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HELP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/12
07:45 am
help
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer [Yahoo! Finance]
Medium
Report
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer [Yahoo! Finance]
3/12
07:30 am
help
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer
Medium
Report
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer
3/9
11:21 am
help
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions [Globe and Mail, The (Toronto, Canada)]
Medium
Report
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions [Globe and Mail, The (Toronto, Canada)]
3/9
01:50 am
help
A Look At Cybin (HELP) Valuation After Positive Phase 2 HLP004 Anxiety Data [Yahoo! Finance]
Medium
Report
A Look At Cybin (HELP) Valuation After Positive Phase 2 HLP004 Anxiety Data [Yahoo! Finance]
3/5
08:08 am
help
Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder [Yahoo! Finance]
High
Report
Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder [Yahoo! Finance]
3/5
07:30 am
help
Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder
High
Report
Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder
3/2
09:27 am
help
Cybin (HELP) had its price target raised by HC Wainwright from $55.00 to $95.00. They now have a "buy" rating on the stock.
Medium
Report
Cybin (HELP) had its price target raised by HC Wainwright from $55.00 to $95.00. They now have a "buy" rating on the stock.
2/27
12:12 pm
help
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments [Globe and Mail, The (Toronto, Canada)]
Low
Report
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments [Globe and Mail, The (Toronto, Canada)]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/12
01:45 pm
help
Form 6-K CYBIN INC. For: Mar 12
Low
Report
Form 6-K CYBIN INC. For: Mar 12
3/5
07:54 am
help
Form 6-K CYBIN INC. For: Mar 05
High
Report
Form 6-K CYBIN INC. For: Mar 05
3/5
06:04 am
help
Form 6-K CYBIN INC. For: Dec 31
High
Report
Form 6-K CYBIN INC. For: Dec 31
2/24
05:17 pm
help
Form 6-K CYBIN INC. For: Feb 24
Low
Report
Form 6-K CYBIN INC. For: Feb 24
2/18
01:56 pm
help
Form 6-K CYBIN INC. For: Feb 18
Low
Report
Form 6-K CYBIN INC. For: Feb 18
2/17
06:21 pm
help
Form SCHEDULE 13G CYBIN INC. Filed by: ORBIMED ADVISORS LLC
Low
Report
Form SCHEDULE 13G CYBIN INC. Filed by: ORBIMED ADVISORS LLC
2/17
05:26 pm
help
Form 6-K CYBIN INC. For: Feb 17
Medium
Report
Form 6-K CYBIN INC. For: Feb 17
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: